Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort

Diana M. Negoescu, Eva A. Enns, Brooke Swanhorst, Bonnie Baumgartner, James P. Campbell, Mark T. Osterman, Konstantinos Papamichael, Adam S. Cheifetz, Byron P. Vaughn

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort'. Together they form a unique fingerprint.

Medicine & Life Sciences